Deep search
Rewards
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
AstraZeneca in AI Collaboration With Immunai to Inform Cancer Drug Trials
(Reuters) - AstraZeneca will pay $18 million to biotechnology firm Immunai Inc to use the New York-based firm's AI model of the immune system to make certain cancer drug trials more efficient, the latter said on Thursday.
Immunai, AstraZeneca collaborate to optimize cancer clinical trials
The initial phase of the collaboration will focus on clinical decision-making processes, such as dose selection, understanding mechanisms of action, distinguishing between patient responders and non-responders,
AstraZeneca's experimental drug disappoints in breast cancer survival trial
AstraZeneca said on Monday its experimental precision drug developed with Japan's Daiichi Sankyo did not significantly improve overall survival for patients with a type of breast cancer in a late-stage trial.
Israeli AI startup forges $18m partnership with AstraZeneca for cancer drug trials
As part of the collaboration, the drugmaker will use Immunai's AI model of the immune system and machine learning for clinical decision-making in drug discovery and development The post Israeli AI startup forges $18m partnership with AstraZeneca for cancer drug trials appeared first on The Times of Israel.
Zacks.com on MSN
2d
AstraZeneca Stock Up Almost 14% in 6 Months: Time to Buy?
AstraZeneca AZN stock has risen 13.6% in the past six months, outperforming an increase of 7.1% for the industry. AstraZeneca ...
MM&M
1d
AstraZeneca’s ‘What science can do’ campaign highlights company’s scientific achievements
In several short films directed by Reed Morano, the “What science can do” campaign features stories from a cancer patient and an asthma patient.
FierceBiotech
2d
AstraZeneca extends AI immuno-oncology R&D pact with Immunai
AstraZeneca is extending its work with Immunai through a multiyear collaboration that aims to implement its ...
2d
AstraZeneca rises Thursday, outperforms market
AstraZeneca PLC AZN shares rallied 1.33% to £117.20 Thursday, on what proved to be an all-around great trading session for ...
2d
AstraZeneca's Top-Selling Cancer Drug Tagrisso Receives FDA Green Light For Another Lung Cancer Indication
The FDA has approved AstraZeneca's Tagrisso for treating unresectable, Stage III EGFR-mutated non-small cell lung cancer, ...
FierceBiotech
5d
AstraZeneca, Daiichi's Trodelvy rival fails to improve overall survival in breast cancer trial
AstraZeneca and Daiichi Sankyo’s TROP2-directed antibody-drug conjugate (ADC) has again failed to improve overall survival ...
FiercePharma
2d
AstraZeneca’s Tagrisso follows up ASCO standing ovation with lung cancer FDA nod
In June, at the American Society of Clinical Oncology (ASCO) conference in Chicago, when AstraZeneca discussed results from a ...
MarketWatch on MSN
4d
AstraZeneca falls Tuesday, underperforms market
Shares of AstraZeneca PLC AZN inched down 0.54% to £115.22 Tuesday, on what proved to be an all-around positive trading ...
2d
AstraZeneca: FDA Approves Tagrisso To Treat Unresectable Stage III Lung Cancer
British drug major AstraZeneca PLC (AZN, AZN.L) announced Thursday that its Tagrisso (osimertinib) has been approved in the US for ...
19h
on MSN
UK considered ‘aquatic raid’ on Netherlands to seize Covid vaccine AstraZeneca: Boris Johnson
United Kingdom considered an "aquatic raid" on a warehouse in Netherlands in order to seize Covid vaccine AstraZeneca during ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Related topics
Immunai
United States
Artificial intelligence
Tagrisso
Food and Drug Administration
Feedback